Cargando…

Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System

Lipid liquid crystalline nanoparticles (LCNPs) are unique nanocarriers that efficiently deliver antimicrobials through biological barriers. Yet, their wide application as an antimicrobial delivery system is hindered by their poor stability in aqueous dispersions. The production of dried LCNP powder...

Descripción completa

Detalles Bibliográficos
Autores principales: Awad, Muhammed, Barnes, Timothy J., Prestidge, Clive A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525386/
https://www.ncbi.nlm.nih.gov/pubmed/37760702
http://dx.doi.org/10.3390/antibiotics12091405
_version_ 1785110773779922944
author Awad, Muhammed
Barnes, Timothy J.
Prestidge, Clive A.
author_facet Awad, Muhammed
Barnes, Timothy J.
Prestidge, Clive A.
author_sort Awad, Muhammed
collection PubMed
description Lipid liquid crystalline nanoparticles (LCNPs) are unique nanocarriers that efficiently deliver antimicrobials through biological barriers. Yet, their wide application as an antimicrobial delivery system is hindered by their poor stability in aqueous dispersions. The production of dried LCNP powder via lyophilization is a promising approach to promote the stability of LCNPs. However, the impact of the process on the functionality of the loaded hydrophobic cargoes has not been reported yet. Herein, we investigated the potential of lyophilization to produce dispersible dry LCNPs loaded with a hydrophobic antimicrobial compound, gallium protoporphyrin (GaPP). The effect of lyophilization on the physicochemical characteristics and the antimicrobial activity of rehydrated GaPP-LCNPs was studied. The rehydrated GaPP-LCNPs retained the liquid crystalline structure and were monodisperse (PDI: 0.27 ± 0.02), with no significant change in nanoparticle concentration despite the minor increase in hydrodynamic diameter (193 ± 6.5 compared to 173 ± 4.2 prior to freeze-drying). Most importantly, the efficacy of the loaded GaPP as an antimicrobial agent and a photosensitizer was not affected as similar MIC values were obtained against S. aureus (0.125 µg/mL), with a singlet oxygen quantum yield of 0.72. These findings indicate the suitability of lyophilization to produce a dry form of LCNPs and pave the way for future studies to promote the application of LCNPs as an antimicrobial delivery system.
format Online
Article
Text
id pubmed-10525386
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105253862023-09-28 Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System Awad, Muhammed Barnes, Timothy J. Prestidge, Clive A. Antibiotics (Basel) Article Lipid liquid crystalline nanoparticles (LCNPs) are unique nanocarriers that efficiently deliver antimicrobials through biological barriers. Yet, their wide application as an antimicrobial delivery system is hindered by their poor stability in aqueous dispersions. The production of dried LCNP powder via lyophilization is a promising approach to promote the stability of LCNPs. However, the impact of the process on the functionality of the loaded hydrophobic cargoes has not been reported yet. Herein, we investigated the potential of lyophilization to produce dispersible dry LCNPs loaded with a hydrophobic antimicrobial compound, gallium protoporphyrin (GaPP). The effect of lyophilization on the physicochemical characteristics and the antimicrobial activity of rehydrated GaPP-LCNPs was studied. The rehydrated GaPP-LCNPs retained the liquid crystalline structure and were monodisperse (PDI: 0.27 ± 0.02), with no significant change in nanoparticle concentration despite the minor increase in hydrodynamic diameter (193 ± 6.5 compared to 173 ± 4.2 prior to freeze-drying). Most importantly, the efficacy of the loaded GaPP as an antimicrobial agent and a photosensitizer was not affected as similar MIC values were obtained against S. aureus (0.125 µg/mL), with a singlet oxygen quantum yield of 0.72. These findings indicate the suitability of lyophilization to produce a dry form of LCNPs and pave the way for future studies to promote the application of LCNPs as an antimicrobial delivery system. MDPI 2023-09-04 /pmc/articles/PMC10525386/ /pubmed/37760702 http://dx.doi.org/10.3390/antibiotics12091405 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Awad, Muhammed
Barnes, Timothy J.
Prestidge, Clive A.
Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System
title Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System
title_full Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System
title_fullStr Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System
title_full_unstemmed Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System
title_short Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System
title_sort lyophilized lipid liquid crystalline nanoparticles as an antimicrobial delivery system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525386/
https://www.ncbi.nlm.nih.gov/pubmed/37760702
http://dx.doi.org/10.3390/antibiotics12091405
work_keys_str_mv AT awadmuhammed lyophilizedlipidliquidcrystallinenanoparticlesasanantimicrobialdeliverysystem
AT barnestimothyj lyophilizedlipidliquidcrystallinenanoparticlesasanantimicrobialdeliverysystem
AT prestidgeclivea lyophilizedlipidliquidcrystallinenanoparticlesasanantimicrobialdeliverysystem